nach oben

Journal of Public Health

Erschienen in:

23.02.2021 | COVID-19 | Review Article Zur Zeit gratis

Incubation period for COVID-19: a systematic review and meta-analysis

verfasst von: Balram Rai, Anandi Shukla, Laxmi Kant Dwivedi

Erschienen in: Journal of Public Health | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Aim

This study aims to conduct a review of the existing literature about incubation period for COVID-19, which can provide insights to the transmission dynamics of the disease.

Methods

A systematic review followed by meta-analysis was performed for the studies providing estimates for the incubation period of COVID-19. The heterogeneity and bias in the included studies were tested by various statistical measures, including I² statistic, Cochran’s Q test, Begg’s test and Egger’s test.

Results

Fifteen studies with 16 estimates of the incubation period were selected after implementing the inclusion and exclusion criteria. The pooled estimate of the incubation period is 5.74 (5.18, 6.30) from the random effects model. The heterogeneity in the selected studies was found to be 95.2% from the I² statistic. There is no potential bias in the included studies for meta-analysis.

Conclusion

This review provides sufficient evidence for the incubation period of COVID-19 through various studies, which can be helpful in planning preventive and control measures for the disease. The pooled estimate from the meta-analysis is a valid and reliable estimate of the incubation period for COVID-19.

Ahrens W, Pigeot I (eds) (2014) Handbook of epidemiology, vol 451. Springer, New York

Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM (2020) Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health 3(7):920–925. https://doi.org/10.1016/j.jiph.2020.05.026. S1876-0341(20)30492-5CrossRef

Backer JA, Klinkenberg D, Wallinga J (2020) Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Eurosurveillance 25(5):2000062CrossRef

Borenstein M, Hedges L, Rothstein H (2007) Meta-analysis: fixed effect vs random effects. Meta-analysis.com. Retrieved from https://www.meta-analysis.com/downloads/Meta-analysis%20fixed%20effect%20vs%20random%20effects%20072607.pdf. Accessed on 5 June 2020

Brookmeyer R (1998) Incubation period of infectious diseases. Encyclopedia of biostatistics, vol 3. Wiley, New York, pp 2011–2016

Centers for Disease Control and Prevention (CDC) (2020) Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection. CDC, Atlanta, GA. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html. Accessed on 10 Dec 2020

Fraser C, Riley S, Anderson RM, Ferguson NM (2004) Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 101(16):6146–6151CrossRef

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720

He G, Sun W, Fang P, Huang J, Gamber M, Cai J, Wu J (2020) The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou. J Med Virol 92(10):1761–1763. https://doi.org/10.1002/jmv.25861CrossRefPubMedPubMedCentral

Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5(1):13CrossRef

Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y, Wang J (2020) Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences 63(5):706–711CrossRef

Ki M (2020) Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiology and Health 42:e2020007. https://doi.org/10.4178/epih.e2020007CrossRefPubMedPubMedCentral

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172(9): 577–582

Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA (2009) Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9(5):291–300CrossRef

Leung C (2020) Estimating the distribution of the incubation period of 2019 novel coronavirus (COVID-19) infection between travelers to Hubei, China and non-travelers. medRxiv. https://doi.org/10.1101/2020.02.13.20022822CrossRefPubMedPubMedCentral

Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y (2020a) COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 92(6):577–583CrossRef

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y ... Xing X (2020b) Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New Engl J Med 382:1199–1207. https://doi.org/10.1056/NEJMoa2001316

Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, et al (2020) Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med 9(2):538

Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al (2020) Transmission dynamics of 2019 novel coronavirus (2019-nCoV). Available at SSRN: https://ssrn.com/abstract=3526307 or https://doi.org/10.2139/ssrn.3526307

Men K, Wang X, Li Y, Zhang G, Hu J, Gao Y, Han H (2020) Estimate the incubation period of coronavirus 2019 (COVID-19). MedRxiv. https://doi.org/10.1101/2020.02.24.20027474CrossRef

Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, ... Gartlehner G (2020) Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev 4(4):CD013574

Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, et al (2020) Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet 396(10250):535–544

Qin J, You C, Lin Q, Hu T, Yu S, Zhou X-H (2020) Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study. MedRxiv. https://doi.org/10.1101/2020.03.06.20032417CrossRefPubMedPubMedCentral

Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R (2020) High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis 26(7):1470–1477. https://doi.org/10.3201/eid2607.200282CrossRefPubMedPubMedCentral

Sterne JA, Harbord RM (2004) Funnel plots in meta-analysis. Stata J 4(2):127–141CrossRef

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012CrossRef

Twu SJ, Chen TJ, Chen CJ et al (2003) Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 9:718–720CrossRef

van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM (2014) Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. BMC Med Res Methodol 14(1):70CrossRef

Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galanis E (2003) Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 169(4):285–292PubMedPubMedCentral

Virlogeux V, Fang VJ, Wu JT, Ho LM, Peiris JM, Leung GM, Cowling BJ (2015) Incubation period duration and severity of clinical disease following severe acute respiratory syndrome coronavirus infection. Epidemiology 26(5):666CrossRef

Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ (2016) Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep 6:35839CrossRef

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135CrossRef

World Health Organization (2003) Update 49 — SARS case fatality ratio, incubation period. WHO, Geneva. https://www.who.int/csr/sars/archive/2003_05_07a/en/. Accessed on 4 June 2020

World Health Organization (2020a) Coronavirus disease 2019 (COVID-19): weekly epidemiological update 22 Dec, 2020. WHO, Geneva. https://www.who.int/publications/m/item/weekly-epidemiological-update---22-december-2020, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200705-covid-19-sitrep-167.pdf?sfvrsn=17e7e3df_4. Accessed on 25 Dec 2020

World Health Organization (2020b) Novel coronavirus (2019-nCoV). Situation report 1. WHO, Geneva. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4. Accessed on 5 July 2020

World Health Organization (2020c) COVID-19 as a public health emergency of international concern (PHEIC) under the IHR. WHO, Geneva. https://extranet.who.int/sph/covid-19-public-health-emergency-international-concern-pheic-under-ihr. Accessed on 5 July 2020

World Health Organization (2020d) WHO Director-General's opening remarks at the media briefing on COVID-19 — 11 March 2020. WHO, Geneva. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Accessed on 5 July 2020

World Health Organization (2020e) COVID-19 Strategy Update — 14 April 2020. WHO, Geneva. https://www.who.int/docs/default-source/coronaviruse/covid-strategy-update-14april2020.pdf?sfvrsn=29da3ba0_19. Accessed on 10 July 2020

Xia W, Liao J, Li C, Li Y, Qian X, Sun X, et al (2020) Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole. MedRxiv.https://doi.org/10.1101/2020.03.06.20031955

Xiao Z, Xie X, Guo W, Luo Z, Liao J, Wen F, Zhou Q, Han L, Zheng T (2020) Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories. J Infect Dev Ctries 14(4):323–327CrossRef

Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, et al (2020) The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: recent advances, prevention, and treatment. Int J Environ Res Public Health 17(7):2323

Yang L, Dai J, Zhao J, Wang Y, Deng P, Wang J (2020) Estimation of incubation period and serial interval of COVID-19: Analysis of 178 cases and 131 transmission chains in Hubei province, China. Epidemiol Infect 148:E117. https://doi.org/10.1017/S0950268820001338CrossRefPubMed

Titel: Incubation period for COVID-19: a systematic review and meta-analysis
verfasst von: Balram Rai
Anandi Shukla
Laxmi Kant Dwivedi
Publikationsdatum: 23.02.2021
Verlag: Springer Berlin Heidelberg
Schlagwörter: COVID-19
Epidemiologie und Hygiene
Diagnostik in der Infektiologie
Pneumonie
Infektionen in der Intensivmedizin
Infektionen in der HNO-Heilkunde
Infektionserkrankungen in der Hausarztpraxis
Erschienen in: Journal of Public Health / Ausgabe 11/2022
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-021-01478-1

Passend zum Thema

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2022

Barriers and facilitators of childhood flu vaccination: the views of parents in North East England

Has the COVID-19 pandemic lockdown worsened eating disorders symptoms among patients with eating disorders? A systematic review

The challenges of drug shortages in the Canadian hospital pharmacy supply chain — a systematic literature review

The effect of local neighbourhood park redevelopments on park visitations and user physical activity levels: a pe–post test evaluation

Spatial clustering and meso-scale correlates of thyroid disorder among women in India: evidence from the National Family Health Survey (2015–16)

A systematic review to identify key elements of effective public health interventions that address barriers to health services for refugees

Passend zum Thema

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen